Floatz logo

DEXAMETHASONE

Bronchopulmonary Dysplasia

National Center for Research Resources (NCRR)Small moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Bronchopulmonary Dysplasia cohort.

Asset / SponsorPhaseRating
Solu-Cortef
National Center for Research Resources (NCRR)
Phase 2B
PERFLUTREN
Thunder Bay Regional Health Research Institute
Early Phase 1C
XENON
Thunder Bay Regional Health Research Institute
Early Phase 1C
Helium
Thunder Bay Regional Health Research Institute
Early Phase 1C
Sonovue
Thunder Bay Regional Health Research Institute
Early Phase 1C
RED BLOOD CELLS
Hospital Clinic of Barcelona
N/AD
Cord Blood Red Blood Cells
Hospital Clinic of Barcelona
N/AD

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →